About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Osteoporosis Drugs Market Size to Reach $12.12 billion by 2031 | Straits Research

Osteoporosis Drugs Market

Osteoporosis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Bisphosphonates, Selective Estrogen Inhibitors Modulator (SERM), Parathyroid Hormone Therapy, Calcitonin, Rank Ligand Inhibitors, Others), By Route of Administration (Oral, Injectable) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH54591DR
Study Period 2019-2031 CAGR 3.5%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 8.9 Billion
Forecast Year 2031 Forecast Year Market Size USD 12.12 Billion
Largest Market North America Fastest Growing Market Europe
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Osteoporosis Drugs Market, By Drug Class (2021-2031)
    1. Bisphosphonates
    2. Selective Estrogen Inhibitors Modulator (SERM)
    3. Parathyroid Hormone Therapy
    4. Calcitonin
    5. Rank Ligand Inhibitors
    6. Others
  2. Osteoporosis Drugs Market, By Route of Administration (2021-2031)
    1. Oral
    2. Injectable
    1. North America
      1. North America Osteoporosis Drugs Market, By Drug Class
        1. Bisphosphonates
          1. Selective Estrogen Inhibitors Modulator (SERM)
            1. Parathyroid Hormone Therapy
              1. Calcitonin
                1. Rank Ligand Inhibitors
                  1. Others
                  2. North America Osteoporosis Drugs Market, By Route of Administration
                    1. Oral
                      1. Injectable
                      2. U.S.
                        1. U.S. Osteoporosis Drugs Market, By Drug Class
                          1. Bisphosphonates
                            1. Selective Estrogen Inhibitors Modulator (SERM)
                              1. Parathyroid Hormone Therapy
                                1. Calcitonin
                                  1. Rank Ligand Inhibitors
                                    1. Others
                                    2. U.S. Osteoporosis Drugs Market, By Route of Administration
                                      1. Oral
                                        1. Injectable
                                      2. Canada
                                    3. Europe
                                      1. Europe Osteoporosis Drugs Market, By Drug Class
                                        1. Bisphosphonates
                                          1. Selective Estrogen Inhibitors Modulator (SERM)
                                            1. Parathyroid Hormone Therapy
                                              1. Calcitonin
                                                1. Rank Ligand Inhibitors
                                                  1. Others
                                                  2. Europe Osteoporosis Drugs Market, By Route of Administration
                                                    1. Oral
                                                      1. Injectable
                                                      2. U.K.
                                                        1. U.K. Osteoporosis Drugs Market, By Drug Class
                                                          1. Bisphosphonates
                                                            1. Selective Estrogen Inhibitors Modulator (SERM)
                                                              1. Parathyroid Hormone Therapy
                                                                1. Calcitonin
                                                                  1. Rank Ligand Inhibitors
                                                                    1. Others
                                                                    2. U.K. Osteoporosis Drugs Market, By Route of Administration
                                                                      1. Oral
                                                                        1. Injectable
                                                                      2. Germany
                                                                      3. France
                                                                      4. Spain
                                                                      5. Italy
                                                                      6. Russia
                                                                      7. Nordic
                                                                      8. Benelux
                                                                      9. Rest of Europe
                                                                    3. APAC
                                                                      1. APAC Osteoporosis Drugs Market, By Drug Class
                                                                        1. Bisphosphonates
                                                                          1. Selective Estrogen Inhibitors Modulator (SERM)
                                                                            1. Parathyroid Hormone Therapy
                                                                              1. Calcitonin
                                                                                1. Rank Ligand Inhibitors
                                                                                  1. Others
                                                                                  2. APAC Osteoporosis Drugs Market, By Route of Administration
                                                                                    1. Oral
                                                                                      1. Injectable
                                                                                      2. China
                                                                                        1. China Osteoporosis Drugs Market, By Drug Class
                                                                                          1. Bisphosphonates
                                                                                            1. Selective Estrogen Inhibitors Modulator (SERM)
                                                                                              1. Parathyroid Hormone Therapy
                                                                                                1. Calcitonin
                                                                                                  1. Rank Ligand Inhibitors
                                                                                                    1. Others
                                                                                                    2. China Osteoporosis Drugs Market, By Route of Administration
                                                                                                      1. Oral
                                                                                                        1. Injectable
                                                                                                      2. Korea
                                                                                                      3. Japan
                                                                                                      4. India
                                                                                                      5. Australia
                                                                                                      6. Taiwan
                                                                                                      7. South East Asia
                                                                                                      8. Rest of Asia-Pacific
                                                                                                    3. Middle East and Africa
                                                                                                      1. Middle East and Africa Osteoporosis Drugs Market, By Drug Class
                                                                                                        1. Bisphosphonates
                                                                                                          1. Selective Estrogen Inhibitors Modulator (SERM)
                                                                                                            1. Parathyroid Hormone Therapy
                                                                                                              1. Calcitonin
                                                                                                                1. Rank Ligand Inhibitors
                                                                                                                  1. Others
                                                                                                                  2. Middle East and Africa Osteoporosis Drugs Market, By Route of Administration
                                                                                                                    1. Oral
                                                                                                                      1. Injectable
                                                                                                                      2. UAE
                                                                                                                        1. UAE Osteoporosis Drugs Market, By Drug Class
                                                                                                                          1. Bisphosphonates
                                                                                                                            1. Selective Estrogen Inhibitors Modulator (SERM)
                                                                                                                              1. Parathyroid Hormone Therapy
                                                                                                                                1. Calcitonin
                                                                                                                                  1. Rank Ligand Inhibitors
                                                                                                                                    1. Others
                                                                                                                                    2. UAE Osteoporosis Drugs Market, By Route of Administration
                                                                                                                                      1. Oral
                                                                                                                                        1. Injectable
                                                                                                                                      2. Turkey
                                                                                                                                      3. Saudi Arabia
                                                                                                                                      4. South Africa
                                                                                                                                      5. Egypt
                                                                                                                                      6. Nigeria
                                                                                                                                      7. Rest of MEA
                                                                                                                                    3. LATAM
                                                                                                                                      1. LATAM Osteoporosis Drugs Market, By Drug Class
                                                                                                                                        1. Bisphosphonates
                                                                                                                                          1. Selective Estrogen Inhibitors Modulator (SERM)
                                                                                                                                            1. Parathyroid Hormone Therapy
                                                                                                                                              1. Calcitonin
                                                                                                                                                1. Rank Ligand Inhibitors
                                                                                                                                                  1. Others
                                                                                                                                                  2. LATAM Osteoporosis Drugs Market, By Route of Administration
                                                                                                                                                    1. Oral
                                                                                                                                                      1. Injectable
                                                                                                                                                      2. Brazil
                                                                                                                                                        1. Brazil Osteoporosis Drugs Market, By Drug Class
                                                                                                                                                          1. Bisphosphonates
                                                                                                                                                            1. Selective Estrogen Inhibitors Modulator (SERM)
                                                                                                                                                              1. Parathyroid Hormone Therapy
                                                                                                                                                                1. Calcitonin
                                                                                                                                                                  1. Rank Ligand Inhibitors
                                                                                                                                                                    1. Others
                                                                                                                                                                    2. Brazil Osteoporosis Drugs Market, By Route of Administration
                                                                                                                                                                      1. Oral
                                                                                                                                                                        1. Injectable
                                                                                                                                                                      2. Mexico
                                                                                                                                                                      3. Argentina
                                                                                                                                                                      4. Chile
                                                                                                                                                                      5. Colombia
                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                  Related Reports

                                                                                                                                                                  Global Report
                                                                                                                                                                  The global psoriasis drug market was valued at USD 12.35 billion in 2023. It is estimated to reach USD 32.89 billion by 2032, growing at a CAGR of 11.50% during the forecast period (2024–2032). The global psoriasis drug market is primarily driv
                                                                                                                                                                  Buy Now

                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                  • Permission to print the report

                                                                                                                                                                  We are featured on :

                                                                                                                                                                  www.straitsresearch.com
                                                                                                                                                                  © Copyright . All rights Reserved.